The 2025 EAU Guidelines on Male Infertility emphasize thorough urological assessment, parallel investigation of the female partner, counseling on associated health risks, and introduce new sections on exome sequencing and probiotic treatment.
Key Findings
Results
All infertile men and men with abnormal semen parameters should be counseled on associated health risks.
The guidelines recommend counseling as a standard part of clinical management for all infertile men
The recommendation reflects that male infertility is associated with broader health risks beyond reproductive outcomes
Strength of recommendations was determined by balancing desirable and undesirable consequences of alternative management strategies, quality of evidence, and patient values and preferences
Results
The 2025 guidelines introduced a new section on exome sequencing as part of the diagnostic work-up for male infertility.
Exome sequencing represents a new addition to the 2025 update, reflecting advances in genetic diagnostics
This section was not present in prior versions of the guidelines
The addition reflects the growing clinical relevance of genetic evaluation in identifying causes of male infertility
Results
The 2025 guidelines introduced a new section on probiotic treatment for male infertility.
Probiotic treatment is identified as a new area of clinical interest added to the 2025 update
This section was not included in previous guideline editions
Its inclusion reflects emerging evidence on the potential role of probiotics in male reproductive health
Results
The guidelines recommend parallel investigation of the female partner during the diagnostic and management work-up of the infertile couple.
Parallel investigation is recommended to 'promote shared-decision making in terms of timing and therapeutic strategies'
The recommendation reflects the clinical relevance of evaluating both partners simultaneously rather than sequentially
This approach is intended to optimize management decisions for the infertile couple as a unit
Results
A thorough urological assessment of all men seeking medical help for fertility problems is recommended to ensure appropriate treatment.
Urological assessment is emphasized as a key recommendation in the 2025 update
The guidelines stress this as a foundational step before initiating treatment
Literature was identified and appraised via structured assessment of Medline, EMBASE, and the Cochrane Libraries databases
Methods
The evidence base and recommendations for the diagnostic work-up of male infertility underwent significant updates in 2025.
The diagnostic work-up section was identified as one of the key areas of significant update for the 2025 guidelines
New and relevant evidence was identified, collated, and appraised via a structured assessment of the literature
Recommendations were developed by the panel to 'prioritise clinically important care decisions'
Methods
Recommendation strength was determined by a multi-factor assessment including quality of evidence, consequences of management strategies, and patient values.
The strength of each recommendation was determined 'according to a balance between desirable and undesirable consequences of alternative management strategies'
Quality of evidence including 'certainty of estimates' was incorporated into recommendation grading
'The nature and variability of patient values and preferences' were also factored into recommendation strength
What This Means
This research presents the 2025 update of the European Association of Urology's guidelines on male infertility, which are evidence-based recommendations designed to help doctors diagnose, treat, and follow up with men who have fertility problems. The guidelines were developed by reviewing the latest medical literature from major databases and were shaped by a panel of experts who weighed the benefits and risks of different clinical approaches. Key updates for 2025 include two entirely new sections — one on genetic testing called exome sequencing, which can help identify genetic causes of infertility, and one on probiotic treatments, reflecting growing interest in whether gut health may influence male reproductive health.
This research suggests that male infertility should not be treated as an isolated reproductive problem. The guidelines strongly recommend that doctors conduct a full urological (urinary and reproductive tract) evaluation of men seeking fertility help, and that both male and female partners be assessed at the same time to enable better-informed, joint decision-making about treatment timing and options. Importantly, the guidelines also emphasize that infertile men and men with abnormal sperm results should be informed about broader health risks that may be associated with their condition, beyond just their fertility.
For patients and clinicians alike, these guidelines provide a structured and updated framework for approaching male infertility in a more comprehensive and personalized way. This research suggests that genetic testing is becoming an increasingly important tool in understanding the root causes of infertility, and that evaluating couples together — rather than one partner at a time — leads to more coordinated and effective care.
Minhas S, Boeri L, Capogrosso P, Cocci A, Corona G, Dinkelman-Smit M, et al.. (2025). European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Infertility.. European urology. https://doi.org/10.1016/j.eururo.2025.02.026